Concurrently, TRF intervention reversed the obesity-induced downregulation of peroxisome proliferator-activated receptor alpha (Ppara) and its coactivator Ppargc1a, which are crucial for activating genes involved in fatty acid catabolism. The gene discussed is PPARA; the disease is obesity due to melanocortin 4 receptor deficiency.